Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McCain Bill Would Upend Supplement NDI Exemptions

This article was originally published in The Tan Sheet

Executive Summary

Sens. John McCain and Byron Dorgan introduced legislation that would undo grandfather status for dietary ingredients established by DSHEA and upend the new dietary ingredient notification process

You may also be interested in...



Hatch Proposes Tougher Penalties For Steroid-Spiked Supplements

Industry trade groups back the Designer Anabolic Steroid Control Act of 2012, which would create stiffer penalties for firms that taint supplements with anabolic steroids and strengthen DEA’s ability to identify and remove products with steroid analogues.

Hatch Proposes Tougher Penalties For Steroid-Spiked Supplements

Industry trade groups back the Designer Anabolic Steroid Control Act of 2012, which would create stiffer penalties for firms that taint supplements with anabolic steroids and strengthen DEA’s ability to identify and remove products with steroid analogues.

Supplement Trade Groups A “Unified Choir,” Leaders Say

Supplement trade groups discuss the strengths and strategies of multiple voices representing the industry.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103778

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel